- AeroClean Technologies Inc's AERC Pūrgo technology has secured U.S. FDA 510(k) clearance, classifying it as a Class II Medical Device.
- The clearance was granted following examination of the patented Pūrgo device, which utilizes patented germicidal UV-C LED air purification technology that has been proven to eliminate 99.99% of harmful airborne microorganisms, including bacteria, fungi, and viruses, like COVID-19.
- The patented technology uses hospital-grade HEPA filtration and optimized germicidal UV irradiation to provide supplemental, localized air cleaning and enhanced ventilation.
- AeroClean provides healthcare facilities, businesses, hospitality venues, and government agencies with medical-grade air purification and air sanitization technology.
- Price Action: AERC shares are trading higher by 39.7% at $3.33 on the last check Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in